|
1
|
Lynam-Lennon N, Maher SG and Reynolds JV:
The roles of microRNA in cancer and apoptosis. Biol Rev Camb Philos
Soc. 84:55–71. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Vandenboom Ii TG, Li Y, Philip PA and
Sarkar FH: MicroRNA and cancer: Tiny molecules with major
implications. Curr Genomics. 9:97–109. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Iorio MV and Croce CM: MicroRNAs in
cancer: Small molecules with a huge impact. J Clin Oncol.
27:5848–5856. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Rachagani S, Kumar S and Batra SK:
MicroRNA in pancreatic cancer: Pathological, diagnostic and
therapeutic implications. Cancer Lett. 292:8–16. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Findlay VJ: MicroRNAs and breast cancer.
Open Cancer J. 3:55–61. 2010.
|
|
6
|
Hwang HW and Mendell JT: MicroRNAs in cell
proliferation, cell death, and tumorigenesis. Br J Cancer.
94:776–780. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Guan H, Dai Z, Ma Y, Wang Z, Liu X and
Wang X: MicroRNA-101 inhibits cell proliferation and induces
apoptosis by targeting EYA1 in breast cancer. Int J Mol Med.
37:1643–1651. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Xiao Y, Tian Q, He J, Huang M, Yang C and
Gong L: MiR-503 inhibits hepatocellular carcinoma cell growth via
inhibition of insulin-like growth factor 1 receptor. Onco Targets
Ther. 9:3535–3544. 2016.PubMed/NCBI
|
|
9
|
Zhu X, Wu L, Yao J, Jiang H, Wang Q, Yang
Z and Wu F: MicroRNA let-7c inhibits cell proliferation and induces
cell cycle arrest by targeting CDC25A in human hepatocellular
carcinoma. PLoS One. 10:e01242662015. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Ding L, Ai D, Wu R, Zhang T, Jing L, Lu J
and Zhong L: Identification of the differential expression of serum
microRNA in type 2 diabetes. Biosci Biotechnol Biochem. 80:461–465.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Lapinski PE, Doosti A, Salato V, North P,
Burrows PE and King PD: Somatic second hit mutation of, RASA1, in
vascular endothelial cells in capillary malformation-arteriovenous
malformation. Euro J Med Genetics. 61:11–16. 2018. View Article : Google Scholar
|
|
12
|
Du C, Weng X, Hu W, Lv Z, Xiao H, Ding C,
Gyabaah OA, Xie H, Zhou L, Wu J and Zheng S: Hypoxia-inducible
MiR-182 promotes angiogenesis by targeting RASA1 in hepatocellular
carcinoma. J Exp Clin Cancer Res. 34:672015. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Sun D, Yu F, Ma Y, Zhao R, Chen X, Zhu J,
Zhang CY, Chen J and Zhang J: MicroRNA-31 activates the RAS pathway
and functions as an oncogenic MicroRNA in human colorectal cancer
by repressing RAS p21 GTPase activating protein 1 (RASA1). J Biol
Chem. 288:9508–9518. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Sun D, Wang C, Long S, Ma Y, Guo Y, Huang
Z, Chen X, Zhang C, Chen J and Zhang J: C/EBP-β-activated
microRNA-223 promotes tumour growth through targeting RASA1 in
human colorectal cancer. Br J Cancer. 112:1491–1500. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Sung H, Kanchi KL, Wang X, Hill KS,
Messina JL, Lee JH, Kim Y, Dees ND, Ding L, Teer JK, et al:
Inactivation of RASA1 promotes melanoma tumorigenesis via R-Ras
activation. Oncotarget. 7:23885–23896. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Lewis BP, Shih IH, Jones-Rhoades MW,
Bartel DP and Burge CB: Prediction of mammalian microRNA targets.
Cell. 115:787–798. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Valencia-Sanchez MA, Liu J, Hannon GJ and
Parker R: Control of translation and mRNA degradation by miRNAs and
siRNAs. Genes Dev. 20:515–524. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Sui Y, Zheng X and Zhao D: Rab31 promoted
hepatocellular carcinoma (HCC) progression via inhibition of cell
apoptosis induced by PI3K/AKT/Bcl-2/BAX pathway. Tumour Biol.
36:8661–8670. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Teodoro JG, Heilman DW, Parker AE and
Green MR: The viral protein Apoptin associates with the
anaphase-promoting complex to induce G2/M arrest and apoptosis in
the absence of p53. Genes Dev. 18:1952–1957. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Mochizuki N, Ohba Y, Kiyokawa E, Kurata T,
Murakami T, Ozaki T, Kitabatake A, Nagashima K and Matsuda M:
Activation of the ERK/MAPK pathway by an isoform of rap1GAP
associated with G alpha(i). Nature. 400:891–894. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Sun Y, Liu WZ, Liu T, Feng X, Yang N and
Zhou HF: Signaling pathway of MAPK/ERK in cell proliferation,
differentiation, migration, senescence and apoptosis. J Recept
Signal Transduct Res. 35:600–604. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Guangda L, Jianbo W and Yingjun N:
Research on the relationship between apoptosis and diabetic
retinopathy. J Clin Ophthalmol. 13:381–383. 2005.
|
|
24
|
Funatsu H, Hori S, Ohashi Y and Ishigaki
T: Risk factors for occurrence and progression of diabetic
retinopathy. Nippon Ganka Gakkai Zasshi. 97:939–946. 1993.(In
Japanese). PubMed/NCBI
|
|
25
|
Hauser D, Katz H, Pokroy R, Bukelman A,
Shechtman E and Pollack A: Occurrence and progression of diabetic
retinopathy after phacoemulsification cataract surgery. J Cataract
Refract Surg. 30:428–432. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Raman R, Ganesan S, Pal SS, Gella L,
Kulothungan V and Sharma T: Incidence and progression of diabetic
retinopathy in urban India: Sankara Nethralaya-Diabetic Retinopathy
Epidemiology and Molecular Genetics Study (SN-DREAMS II), Report 1.
Ophthal Epidemiol. 24:294–302. 2017. View Article : Google Scholar
|
|
27
|
Zhang T, Jing L, Li H, Ding L, Ai D, Lyu J
and Zhong L: MicroRNA-4530 promotes angiogenesis by targeting VASH1
in breast carcinoma cells. Oncol Lett. 14:111–118. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Hicklin DJ and Ellis LM: Role of the
vascular endothelial growth factor pathway in tumor growth and
angiogenesis. J Clin Oncol. 23:1011–1027. 2015. View Article : Google Scholar
|
|
29
|
Gong B, Liu WW, Nie WJ, Li DF, Xie ZJ, Liu
C, Liu YH, Mei P and Li ZJ: MiR-21/RASA1 axis affects malignancy of
colon cancer cells via RAS pathways. World J Gastroenterol.
21:1488–1497. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Li X, Li D, Wikstrom JD, Pivarcsi A,
Sonkoly E, Ståhle M and Landén NX: MicroRNA-132 promotes fibroblast
migration via regulating RAS p21 protein activator 1 in skin wound
healing. Sci Rep. 7:77972017. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Sharma SB, Lin CC, Farrugia MK, McLaughlin
SL, Ellis EJ, Brundage KM, Salkeni MA and Ruppert JM: MicroRNAs 206
and 21 cooperate to promote RAS-extracellular signal-regulated
kinase signaling by suppressing the translation of RASA1 and
SPRED1. Mol Cell Biol. 34:4143–4164. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Vasudevan S, Tong Y and Steitz JA:
Switching from repression to activation: MicroRNAs can up-regulate
translation. Science. 318:1931–1934. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Cordes KR, Sheehy NT, White MP, Berry EC,
Morton SU, Muth AN, Lee TH, Miano JM, Ivey KN and Srivastava D:
miR-145 and miR-143 regulate smooth muscle cell fate and
plasticity. Nature. 460:705–710. 2009.PubMed/NCBI
|
|
34
|
Xin M and Deng X: Nicotine inactivation of
the proapoptotic function of Bax through phosphorylation. J Biol
Chem. 280:10781–10789. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Shultz JC, Goehe RW, Wijesinghe DS,
Murudkar C, Hawkins AJ, Shay JW, Minna JD and Chalfant CE:
Alternative splicing of caspase 9 is modulated by the
phosphoinositide 3-kinase/Akt pathway via phosphorylation of
SRp30a. Cancer Res. 70:9185–9196. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Zhang Y, Liu D, Chen X, Li J, Li L, Bian
Z, Sun F, Lu J, Yin Y, Cai X, et al: Secreted monocytic miR-150
enhances targeted endothelial cell migration. Mol Cell. 39:133–144.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Kolch W: Coordinating ERK/MAPK signalling
through scaffolds and inhibitors. Nat Rev Mol Cell Biol. 6:827–837.
2005. View
Article : Google Scholar : PubMed/NCBI
|
|
38
|
Choi YS, Cho HY, Hoyt KR, Naegele JR and
Obrietan K: IGF-1 receptor-mediated ERK/MAPK signaling couples
status epilepticus to progenitor cell proliferation in the
subgranular layer of the dentate gyrus. Glia. 56:791–800. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Jaiswal K, Lopez-Guzman C, Souza RF,
Spechler SJ and Sarosi GA Jr: Bile salt exposure increases
proliferation through p38 and ERK MAPK pathways in a non-neoplastic
Barrett's cell line. Am J Physiol Gastrointest Liver Physiol.
290:G335–G342. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Wu XS, Walbladng XA, Wu WG, Hu YP, Li ML,
Ding Q, Weng H, Shu YJ, Liu TY, Jiang L, et al: MALAT1 promotes the
proliferation and metastasis of gallbladder cancer cells by
activating the ERK/MAPK pathway. Cancer Biol Ther. 15:806–814.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Kojima M, Sudo H, Kawauchi J, Takizawa S,
Kondou S, Nobumasa H and Ochiai A: MicroRNA markers for the
diagnosis of pancreatic and biliary-tract cancers. PLoS One.
10:e01182202015. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Xun M, Ma CF, Du QL, Ji YH and Xu JR:
Differential expression of miRNAs in enterovirus 71-infected cells.
Virol J. 12:562015. View Article : Google Scholar : PubMed/NCBI
|
